US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
EP0504881B2
(de)
*
|
1991-03-22 |
2000-11-08 |
Katsuro Tachibana |
Verstärker zur Ultraschalltherapie von Erkrankungen sowie diesen enthaltende flüssige Arzneimittelzusammensetzungen
|
GB9106673D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
MX9205298A
(es)
*
|
1991-09-17 |
1993-05-01 |
Steven Carl Quay |
Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
|
IL108416A
(en)
|
1993-01-25 |
1998-10-30 |
Sonus Pharma Inc |
Colloids with phase difference as contrast ultrasound agents
|
SG52198A1
(en)
*
|
1993-01-25 |
1998-09-28 |
Sonus Pharma Inc |
Phase shift colloids as ultrasound contrast agents
|
SE504074C2
(sv)
*
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
US5798091A
(en)
|
1993-07-30 |
1998-08-25 |
Alliance Pharmaceutical Corp. |
Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
|
DK0711179T3
(da)
*
|
1993-07-30 |
2005-02-14 |
Imcor Pharmaceutical Co |
Stabiliserede sammensætninger med mikrobobler til ultralyd
|
US6217849B1
(en)
*
|
1993-09-29 |
2001-04-17 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
CZ208995A3
(en)
*
|
1993-12-15 |
1996-01-17 |
Bracco Research Sa |
Injectable ultrasound medium, process of its preparation and use
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US5792612A
(en)
*
|
1994-06-22 |
1998-08-11 |
Helsinki University Licensing, Ltd. |
Use of lipids to improve the polymerse chain reaction
|
US5730955A
(en)
*
|
1994-08-02 |
1998-03-24 |
Molecular Biosystems, Inc. |
Process for making gas-filled microspheres containing a liquid hydrophobic barrier
|
US5540909A
(en)
*
|
1994-09-28 |
1996-07-30 |
Alliance Pharmaceutical Corp. |
Harmonic ultrasound imaging with microbubbles
|
US6743779B1
(en)
*
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6383814B1
(en)
*
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
USRE38971E1
(en)
|
1995-01-31 |
2006-02-07 |
Kabushiki Kaisha Toshiba |
Ultrasound diagnostic apparatus and method
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5902604A
(en)
*
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
GB9511488D0
(en)
*
|
1995-06-07 |
1995-08-02 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US5804162A
(en)
*
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US5897851A
(en)
*
|
1995-06-07 |
1999-04-27 |
Sonus Pharmaceuticals, Inc. |
Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
|
US5780010A
(en)
*
|
1995-06-08 |
1998-07-14 |
Barnes-Jewish Hospital |
Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
|
US6821506B2
(en)
*
|
1995-06-08 |
2004-11-23 |
Barnes-Jewish Hospital |
Site specific binding system, imaging compositions and methods
|
DE19543077C2
(de)
*
|
1995-11-13 |
1997-10-16 |
Schering Ag |
Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
|
US5840276A
(en)
*
|
1996-01-11 |
1998-11-24 |
Apfel Enterprises, Inc. |
Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis
|
PT881915E
(pt)
*
|
1996-02-19 |
2003-09-30 |
Amersham Health As |
Melhorias em ou relativas a agentes de contraste
|
JP3956402B2
(ja)
*
|
1996-03-04 |
2007-08-08 |
日本油脂株式会社 |
アンホテリシンb運搬体
|
DK0904113T3
(da)
*
|
1996-03-05 |
2004-08-30 |
Acusphere Inc |
Mikroindkapslede fluorerede gasser til anvendelse som billeddannende midler
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
JP2947158B2
(ja)
*
|
1996-03-07 |
1999-09-13 |
昭和電工株式会社 |
ヘキサフルオロエタンの製造方法
|
AU2549297A
(en)
|
1996-03-28 |
1997-10-17 |
Board Of Trustees Of The University Of Illinois, The |
Materials and methods for making improved echogenic liposome compositions
|
AU736301B2
(en)
*
|
1996-05-01 |
2001-07-26 |
Imarx Therapeutics, Inc. |
Methods for delivering compounds into a cell
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
WO1998007410A1
(en)
*
|
1996-08-19 |
1998-02-26 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
ATE252372T1
(de)
*
|
1996-08-23 |
2003-11-15 |
Sequus Pharm Inc |
Liposome enthaltend cisplatin
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
CA2263568C
(en)
|
1996-09-11 |
2008-12-02 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a contrast agent and a renal vasodilator
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
WO1998013024A2
(en)
*
|
1996-09-27 |
1998-04-02 |
Hyal Pharmaceutical Corporation |
Hyaluronic drug delivery system
|
DE69738406T2
(de)
|
1996-10-21 |
2008-12-04 |
Ge Healthcare As |
Verbesserungen in oder an Kontrastmitteln
|
DE19648664A1
(de)
*
|
1996-11-14 |
1998-05-28 |
Schering Ag |
Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
GB9701237D0
(en)
*
|
1997-01-22 |
1997-03-12 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6676626B1
(en)
|
1998-05-01 |
2004-01-13 |
Ekos Corporation |
Ultrasound assembly with increased efficacy
|
US6582392B1
(en)
|
1998-05-01 |
2003-06-24 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US6416740B1
(en)
*
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
AU726115C
(en)
*
|
1997-08-12 |
2001-12-20 |
Bracco Research S.A. |
Administrable compositions and methods for magnetic resonance imaging
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
EP1019020A1
(de)
*
|
1997-09-29 |
2000-07-19 |
Inhale Therapeutic Systems, Inc. |
Stabilisierte, bioaktive zubereitungen und ihre verwendung
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US7637948B2
(en)
|
1997-10-10 |
2009-12-29 |
Senorx, Inc. |
Tissue marking implant
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
WO1999020312A1
(en)
*
|
1997-10-21 |
1999-04-29 |
Nycomed Imaging As |
Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
|
US9198635B2
(en)
|
1997-10-31 |
2015-12-01 |
University Of Washington |
Method and apparatus for preparing organs and tissues for laparoscopic surgery
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
JPH11244386A
(ja)
*
|
1998-01-01 |
1999-09-14 |
Ge Yokogawa Medical Systems Ltd |
血行阻止方法及び加温装置
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6896659B2
(en)
*
|
1998-02-06 |
2005-05-24 |
Point Biomedical Corporation |
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
|
US6161034A
(en)
*
|
1999-02-02 |
2000-12-12 |
Senorx, Inc. |
Methods and chemical preparations for time-limited marking of biopsy sites
|
ATE276745T1
(de)
*
|
1998-04-09 |
2004-10-15 |
Amersham Health As |
Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter
|
US20030078227A1
(en)
*
|
1998-07-02 |
2003-04-24 |
Greenleaf James F. |
Site-directed transfection with ultrasound and cavitation nuclei
|
US7686763B2
(en)
*
|
1998-09-18 |
2010-03-30 |
University Of Washington |
Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy
|
EP1140211A1
(de)
*
|
1998-10-12 |
2001-10-10 |
Mallinckrodt Inc. |
Ultraschall kontrastmitteln
|
US8361082B2
(en)
|
1999-02-02 |
2013-01-29 |
Senorx, Inc. |
Marker delivery device with releasable plug
|
US7651505B2
(en)
*
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US6862470B2
(en)
|
1999-02-02 |
2005-03-01 |
Senorx, Inc. |
Cavity-filling biopsy site markers
|
US7983734B2
(en)
|
2003-05-23 |
2011-07-19 |
Senorx, Inc. |
Fibrous marker and intracorporeal delivery thereof
|
US20090030309A1
(en)
|
2007-07-26 |
2009-01-29 |
Senorx, Inc. |
Deployment of polysaccharide markers
|
US6725083B1
(en)
|
1999-02-02 |
2004-04-20 |
Senorx, Inc. |
Tissue site markers for in VIVO imaging
|
US9820824B2
(en)
|
1999-02-02 |
2017-11-21 |
Senorx, Inc. |
Deployment of polysaccharide markers for treating a site within a patent
|
US8498693B2
(en)
|
1999-02-02 |
2013-07-30 |
Senorx, Inc. |
Intracorporeal marker and marker delivery device
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
KR100642955B1
(ko)
|
1999-04-23 |
2006-11-10 |
알자 코포레이션 |
방출성 결합 및 그를 함유하는 조성물
|
US6575991B1
(en)
|
1999-06-17 |
2003-06-10 |
Inrad, Inc. |
Apparatus for the percutaneous marking of a lesion
|
US6572840B1
(en)
|
1999-07-28 |
2003-06-03 |
Bristol-Myers Squibb Pharma Company |
Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
|
WO2001012069A1
(en)
*
|
1999-08-13 |
2001-02-22 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
US7510536B2
(en)
|
1999-09-17 |
2009-03-31 |
University Of Washington |
Ultrasound guided high intensity focused ultrasound treatment of nerves
|
US7520856B2
(en)
|
1999-09-17 |
2009-04-21 |
University Of Washington |
Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology
|
JP4776843B2
(ja)
|
1999-10-01 |
2011-09-21 |
イムノゲン インコーポレーティッド |
免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
|
AU2619301A
(en)
|
1999-10-25 |
2001-06-06 |
Therus Corporation |
Use of focused ultrasound for vascular sealing
|
US6626855B1
(en)
|
1999-11-26 |
2003-09-30 |
Therus Corpoation |
Controlled high efficiency lesion formation using high intensity ultrasound
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
CA2733819A1
(en)
*
|
1999-12-30 |
2001-07-12 |
Judith K. Gwathmey |
Iron chelator delivery system
|
WO2001066016A1
(en)
*
|
2000-03-06 |
2001-09-13 |
Scimed Life Systems, Inc. |
Embolic agents visible under ultrasound
|
JP2003528131A
(ja)
*
|
2000-03-29 |
2003-09-24 |
アラダイム コーポレーション |
カチオン性リポソーム
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
MXPA02001323A
(es)
|
2000-05-10 |
2004-07-16 |
Alliance Pharma |
Microgranulos con base fosfolipida para la liberacion de farmaco.
|
CA2410052A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Delivery systems for bioactive agents
|
AU2001266696A1
(en)
|
2000-06-02 |
2001-12-11 |
Bracco Research Usa |
Compounds for targeting endothelial cells
|
US6800297B2
(en)
|
2000-06-15 |
2004-10-05 |
Acusphere, Inc. |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
|
US6589557B2
(en)
*
|
2000-06-15 |
2003-07-08 |
Acusphere, Inc. |
Porous celecoxib matrices and methods of manufacture thereof
|
ES2312448T3
(es)
*
|
2000-06-16 |
2009-03-01 |
Sloan-Kettering Institute For Cancer Research |
Encapsulacion liposomica de emisores alfa y sus usos.
|
US6599441B1
(en)
*
|
2000-07-18 |
2003-07-29 |
Emerald Biostructures, Inc. |
Crystallization solutions
|
US7311893B2
(en)
*
|
2000-07-25 |
2007-12-25 |
Neurochem (International) Limited |
Amyloid targeting imaging agents and uses thereof
|
AU2002239290A1
(en)
|
2000-11-20 |
2002-06-03 |
Senorx, Inc. |
Tissue site markers for in vivo imaging
|
DK1347743T3
(da)
*
|
2000-12-07 |
2006-07-03 |
Univ Utrecht Holding Bv |
Præparat til behandling af inflammatoriske lidelser
|
US7179449B2
(en)
*
|
2001-01-30 |
2007-02-20 |
Barnes-Jewish Hospital |
Enhanced ultrasound detection with temperature-dependent contrast agents
|
US20030211045A1
(en)
*
|
2001-02-05 |
2003-11-13 |
Danuta Leszcyznska |
Magnetoliposome composition for targeted treatment of biological tissue and associated methods
|
US7897141B2
(en)
*
|
2002-04-01 |
2011-03-01 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
AU2002307056B2
(en)
*
|
2001-03-30 |
2005-08-04 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
JP4426288B2
(ja)
*
|
2001-07-10 |
2010-03-03 |
ソノジーン,リミテッド ライアビリティー カンパニー |
肝臓へのdnaのトランスフェクションの増強
|
US20030215391A1
(en)
*
|
2001-07-19 |
2003-11-20 |
Carlos Rabito |
Fluorescent agents for real-time measurement of organ function
|
US20030044354A1
(en)
*
|
2001-08-16 |
2003-03-06 |
Carpenter Alan P. |
Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
|
US7344702B2
(en)
*
|
2004-02-13 |
2008-03-18 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardial perfusion imaging
|
US20050065118A1
(en)
*
|
2001-10-16 |
2005-03-24 |
Jing Wang |
Organosulfur inhibitors of tyrosine phosphatases
|
AU2002359576A1
(en)
|
2001-12-03 |
2003-06-17 |
Ekos Corporation |
Catheter with multiple ultrasound radiating members
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US6993394B2
(en)
|
2002-01-18 |
2006-01-31 |
Calfacion Corporation |
System method and apparatus for localized heating of tissue
|
US6850804B2
(en)
|
2002-01-18 |
2005-02-01 |
Calfacior Corporation |
System method and apparatus for localized heating of tissue
|
US7048756B2
(en)
|
2002-01-18 |
2006-05-23 |
Apasara Medical Corporation |
System, method and apparatus for evaluating tissue temperature
|
US7700074B2
(en)
*
|
2002-02-07 |
2010-04-20 |
Pettegrew Jay W |
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
US7407778B2
(en)
*
|
2002-02-07 |
2008-08-05 |
Pettegrew Jay W |
Compounds, compositions and methods for treating neuropsychiatric disorders
|
US7985402B2
(en)
*
|
2002-03-01 |
2011-07-26 |
Bracco Suisse Sa |
Targeting vector-phospholipid conjugates
|
US7211240B2
(en)
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
EP1572724A4
(de)
|
2002-03-01 |
2007-03-14 |
Dyax Corp |
Kdr und vegf/kdr bindungspeptide und ihre verwendung bei der diagnose und therapie
|
US7666979B2
(en)
*
|
2002-03-01 |
2010-02-23 |
Bracco International B.V. |
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
|
WO2004065621A1
(en)
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
US7794693B2
(en)
*
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
US20050250700A1
(en)
*
|
2002-03-01 |
2005-11-10 |
Sato Aaron K |
KDR and VEGF/KDR binding peptides
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US7094369B2
(en)
*
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
US8226629B1
(en)
|
2002-04-01 |
2012-07-24 |
Ekos Corporation |
Ultrasonic catheter power control
|
DE10214983A1
(de)
*
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US20040042972A1
(en)
*
|
2002-04-11 |
2004-03-04 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
AU2003234090A1
(en)
*
|
2002-04-11 |
2003-10-27 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for pulmonary administration
|
US8829198B2
(en)
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
EP1371362A1
(de)
*
|
2002-06-12 |
2003-12-17 |
Universiteit Utrecht Holding B.V. |
Zusammensetzung zur Behandlung entzündlicher Erkrankungen
|
WO2003105917A2
(en)
|
2002-06-12 |
2003-12-24 |
Scimed Life Systems, Inc. |
Bulking agents
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
WO2004002476A2
(en)
|
2002-06-27 |
2004-01-08 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
WO2004005289A2
(en)
*
|
2002-07-02 |
2004-01-15 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
US20040076582A1
(en)
*
|
2002-08-30 |
2004-04-22 |
Dimatteo Kristian |
Agent delivery particle
|
US7842377B2
(en)
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
EP1393720A1
(de)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
AU2003275103A1
(en)
*
|
2002-09-17 |
2004-04-08 |
Diffusion Science, Inc. |
Electrochemical generation, storage and reaction of hydrogen and oxygen using gas permeable catalyst-coated hollow microspheres
|
US6921371B2
(en)
|
2002-10-14 |
2005-07-26 |
Ekos Corporation |
Ultrasound radiating members for catheter
|
US7883490B2
(en)
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
US20060036158A1
(en)
|
2003-11-17 |
2006-02-16 |
Inrad, Inc. |
Self-contained, self-piercing, side-expelling marking apparatus
|
WO2004060343A1
(en)
*
|
2002-12-31 |
2004-07-22 |
Nektar Therapeutics |
Antibody-containing particles and compositions
|
WO2004078778A2
(en)
|
2003-03-03 |
2004-09-16 |
Dyax Corp. |
PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
|
US20040258761A1
(en)
*
|
2003-03-20 |
2004-12-23 |
Wheatley Margaret A. |
Polymer-based microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
|
US20060198882A1
(en)
*
|
2003-03-21 |
2006-09-07 |
Yechezkel Barenholz |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
WO2004099158A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Monocyclic diazodioxide based bcl-2 protein antagonists
|
WO2004099162A1
(en)
*
|
2003-04-30 |
2004-11-18 |
Ricerca Biosciences, Llc. |
Polycyclic diazodioxide-based bcl-2 protein antagonist
|
CN102584813B
(zh)
*
|
2003-05-14 |
2016-07-06 |
Ngc药物公司 |
化合物及其在调节淀粉样蛋白β中的用途
|
US7877133B2
(en)
|
2003-05-23 |
2011-01-25 |
Senorx, Inc. |
Marker or filler forming fluid
|
CN1795198B
(zh)
*
|
2003-05-29 |
2011-08-17 |
杰伊·W·佩特格尤 |
对神经精神疾病进行医学成像所用的甘油磷酸胆碱及其衍生物
|
US20060257842A1
(en)
*
|
2003-05-29 |
2006-11-16 |
Pettegrew Jay W |
Cryopreservation media and molecules
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US7358226B2
(en)
*
|
2003-08-27 |
2008-04-15 |
The Regents Of The University Of California |
Ultrasonic concentration of drug delivery capsules
|
US7976823B2
(en)
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
US20050106101A1
(en)
*
|
2003-10-31 |
2005-05-19 |
Ajay Purohit |
Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
|
US7901770B2
(en)
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
US20050273002A1
(en)
|
2004-06-04 |
2005-12-08 |
Goosen Ryan L |
Multi-mode imaging marker
|
US8568632B2
(en)
*
|
2003-11-26 |
2013-10-29 |
Owens Corning Intellectual Capital, Llc |
Method of forming thermoplastic foams using nano-particles to control cell morphology
|
US9359481B2
(en)
*
|
2003-11-26 |
2016-06-07 |
Owens Corning Intellectual Capital, Llc |
Thermoplastic foams and method of forming them using nano-graphite
|
US20080287560A1
(en)
*
|
2004-12-31 |
2008-11-20 |
Loh Roland R |
Polymer foams containing multi-functional layered nano-graphite
|
US8211017B2
(en)
|
2003-12-16 |
2012-07-03 |
University Of Washington |
Image guided high intensity focused ultrasound treatment of nerves
|
CA2553690C
(en)
|
2004-01-22 |
2016-05-24 |
Sung Lan Hsia |
Topical co-enzyme q10 formulations and methods of use
|
US7201737B2
(en)
|
2004-01-29 |
2007-04-10 |
Ekos Corporation |
Treatment of vascular occlusions using elevated temperatures
|
US7341569B2
(en)
*
|
2004-01-30 |
2008-03-11 |
Ekos Corporation |
Treatment of vascular occlusions using ultrasonic energy and microbubbles
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US7736671B2
(en)
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
US7485283B2
(en)
|
2004-04-28 |
2009-02-03 |
Lantheus Medical Imaging |
Contrast agents for myocardial perfusion imaging
|
US20050261365A1
(en)
|
2004-05-20 |
2005-11-24 |
The Scripps Research Institute |
Transthyretin stabilization
|
US7311861B2
(en)
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US7306716B2
(en)
*
|
2004-06-16 |
2007-12-11 |
Access Business Group International Llc |
Water treatment system
|
WO2006009876A2
(en)
*
|
2004-06-17 |
2006-01-26 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
EP1786421A2
(de)
*
|
2004-07-09 |
2007-05-23 |
Cengent Therapeutics, Inc. |
Sauerstoff/stickstoff-heterozyklus-hemmer von tyrosinphosphatasen
|
US9066679B2
(en)
|
2004-08-31 |
2015-06-30 |
University Of Washington |
Ultrasonic technique for assessing wall vibrations in stenosed blood vessels
|
EP1841749A1
(de)
*
|
2004-09-02 |
2007-10-10 |
Metabasis Therapeutics, Inc. |
Thiazol- und thiadiazolderivate als inhibitoren von tyrosinphosphatasen
|
US20080009561A1
(en)
*
|
2004-09-03 |
2008-01-10 |
Imarx Therapeutics, Inc. |
Apparatus And Method To Prepare A Microsphere-Forming Composition
|
WO2006032059A2
(en)
*
|
2004-09-16 |
2006-03-23 |
University Of Washington |
Acoustic coupler using an independent water pillow with circulation for cooling a transducer
|
EP1802303B1
(de)
|
2004-09-17 |
2011-11-02 |
Whitehead Institute For Biomedical Research |
Verbindungen, zusammensetzungen und verfahren zur verhinderung einer a-synuklein-vergiftung
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
DE602005008270D1
(de)
*
|
2004-10-08 |
2008-08-28 |
Alza Corp |
Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen
|
US8425550B2
(en)
|
2004-12-01 |
2013-04-23 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US8173170B2
(en)
|
2004-12-22 |
2012-05-08 |
Nitto Denko Corporation |
Drug carrier and drug carrier kit for inhibiting fibrosis
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
CN100427142C
(zh)
*
|
2005-01-10 |
2008-10-22 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用助剂及其筛选方法
|
ATE531389T1
(de)
|
2005-01-28 |
2011-11-15 |
Univ Northwest |
Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US7727555B2
(en)
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
US8153435B1
(en)
|
2005-03-30 |
2012-04-10 |
Tracer Detection Technology Corp. |
Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
|
EP1866319B1
(de)
|
2005-04-01 |
2011-11-23 |
The Regents of The University of California |
Phosphono-pent-2-en-1-yl-nukleoside und analoga
|
US20090156545A1
(en)
*
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
CA2604380A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Ekos Corporation |
Ultrasound catheter with cavitation promoting surface
|
EP1714642A1
(de)
*
|
2005-04-18 |
2006-10-25 |
Bracco Research S.A. |
Pharmazeutische Formulierung mit gasgefüllten Mikrokapseln zur ultraschallgesteuerten Freisetzung
|
US10357328B2
(en)
|
2005-04-20 |
2019-07-23 |
Bard Peripheral Vascular, Inc. and Bard Shannon Limited |
Marking device with retractable cannula
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
EP1884232A1
(de)
*
|
2005-05-23 |
2008-02-06 |
Mebiopharm Co., Ltd. |
Verfahren zur herstellung von liposomen mit darin eingeschlossenem gas
|
WO2006129099A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Cancercure Technology As |
Ultrasound treatment system
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US9463426B2
(en)
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
US7824659B2
(en)
|
2005-08-10 |
2010-11-02 |
Lantheus Medical Imaging, Inc. |
Methods of making radiolabeled tracers and precursors thereof
|
US9011473B2
(en)
|
2005-09-07 |
2015-04-21 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US10548659B2
(en)
|
2006-01-17 |
2020-02-04 |
Ulthera, Inc. |
High pressure pre-burst for improved fluid delivery
|
US9358033B2
(en)
|
2005-09-07 |
2016-06-07 |
Ulthera, Inc. |
Fluid-jet dissection system and method for reducing the appearance of cellulite
|
US9486274B2
(en)
|
2005-09-07 |
2016-11-08 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US8518069B2
(en)
|
2005-09-07 |
2013-08-27 |
Cabochon Aesthetics, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9187608B2
(en)
*
|
2005-09-08 |
2015-11-17 |
Owens Corning Intellectual Capital, Llc |
Polystyrene foam containing a modifier-free nanoclay and having improved fire protection performance
|
WO2007035529A2
(en)
|
2005-09-16 |
2007-03-29 |
University Of Washington |
Thin-profile therapeutic ultrasound applicators
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
US8016757B2
(en)
|
2005-09-30 |
2011-09-13 |
University Of Washington |
Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound
|
CA2562580C
(en)
|
2005-10-07 |
2014-04-29 |
Inrad, Inc. |
Drug-eluting tissue marker
|
US8007509B2
(en)
|
2005-10-12 |
2011-08-30 |
Boston Scientific Scimed, Inc. |
Coil assemblies, components and methods
|
US20070213616A1
(en)
|
2005-10-20 |
2007-09-13 |
Thomas Anderson |
Systems and methods for arteriotomy localization
|
US8257338B2
(en)
*
|
2006-10-27 |
2012-09-04 |
Artenga, Inc. |
Medical microbubble generation
|
US9248317B2
(en)
*
|
2005-12-02 |
2016-02-02 |
Ulthera, Inc. |
Devices and methods for selectively lysing cells
|
US20080200864A1
(en)
*
|
2005-12-02 |
2008-08-21 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US20080014627A1
(en)
*
|
2005-12-02 |
2008-01-17 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US20080195036A1
(en)
*
|
2005-12-02 |
2008-08-14 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US7885793B2
(en)
|
2007-05-22 |
2011-02-08 |
International Business Machines Corporation |
Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
|
WO2007070827A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardium perfusion imaging
|
US8152839B2
(en)
|
2005-12-19 |
2012-04-10 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US8101197B2
(en)
|
2005-12-19 |
2012-01-24 |
Stryker Corporation |
Forming coils
|
US7947368B2
(en)
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
WO2007087418A2
(en)
*
|
2006-01-24 |
2007-08-02 |
Imarx Therapeutics, Inc. |
Composition and method for neuromuscular blockade
|
US20070184085A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Boston Scientific Scimed, Inc. |
Ultrasound activated medical device
|
US20070184076A1
(en)
*
|
2006-02-07 |
2007-08-09 |
Unger Evan C |
Liquid-filled nanodroplets for anti-cancer therapy
|
EP2013182B1
(de)
|
2006-03-13 |
2013-09-04 |
Kyorin Pharmaceutical Co., Ltd. |
Aminochinolone als gsk-3-hemmer
|
CN101460161A
(zh)
*
|
2006-03-29 |
2009-06-17 |
弗尔德里克斯制药股份有限公司 |
α-突触核蛋白毒性的抑制
|
US20070265560A1
(en)
*
|
2006-04-24 |
2007-11-15 |
Ekos Corporation |
Ultrasound Therapy System
|
AU2007244705A1
(en)
*
|
2006-04-27 |
2007-11-08 |
Barnes-Jewish Hospital |
Detection and imaging of target tissue
|
WO2007137236A2
(en)
*
|
2006-05-19 |
2007-11-29 |
Drexel University |
Drug loaded contrast agents: combining diagnosis and therapy
|
MY162024A
(en)
|
2006-08-28 |
2017-05-31 |
La Jolla Inst Allergy & Immunology |
Antagonistic human light-specific human monoclonal antibodies
|
US20070080613A1
(en)
*
|
2006-09-20 |
2007-04-12 |
Sterlite Optical Technologies Ltd |
Storage and transportation device for storing and transporting optical fiber preform and precursors thereof
|
MX2009002960A
(es)
|
2006-09-21 |
2009-06-26 |
Activx Biosciences Inc |
Inhibidores de serina hidrolasa.
|
BRPI0715579A2
(pt)
|
2006-10-19 |
2015-05-26 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica e uso de um composto"
|
US8064987B2
(en)
|
2006-10-23 |
2011-11-22 |
C. R. Bard, Inc. |
Breast marker
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
US20100137421A1
(en)
*
|
2006-11-08 |
2010-06-03 |
Emmanuel Theodorakis |
Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
|
US9579077B2
(en)
|
2006-12-12 |
2017-02-28 |
C.R. Bard, Inc. |
Multiple imaging mode tissue marker
|
US8401622B2
(en)
|
2006-12-18 |
2013-03-19 |
C. R. Bard, Inc. |
Biopsy marker with in situ-generated imaging properties
|
CA2673566A1
(en)
|
2006-12-19 |
2008-06-26 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of ccr5 inhibitors
|
WO2008079371A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
US10182833B2
(en)
|
2007-01-08 |
2019-01-22 |
Ekos Corporation |
Power parameters for ultrasonic catheter
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
AU2008219622A1
(en)
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors
|
CA2680912C
(en)
|
2007-03-15 |
2017-11-14 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
|
WO2008116135A2
(en)
|
2007-03-22 |
2008-09-25 |
Cytotech Labs, Llc |
Topical formulations having enhanced bioavailability
|
US20080242752A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Yadollah Delaviz |
Polystyrene foams incorporating nanographite and HFC-134
|
TWI407971B
(zh)
*
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
EP2148659A2
(de)
*
|
2007-04-13 |
2010-02-03 |
Somaxon Pharmaceuticals, Inc. |
Niedrigdosierte doxepin-formulierungen
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
ES2471118T3
(es)
|
2007-06-22 |
2014-06-25 |
Ekos Corporation |
Método y aparato para el tratamiento de hemorragias intracraneales
|
BRPI0814542A2
(pt)
*
|
2007-07-12 |
2014-09-30 |
Tragara Pharmaceuticals Inc |
Métodos e composições para o tratamento de câncer, tumores e desordens relacionadas a tumores
|
BRPI0816798A2
(pt)
*
|
2007-09-11 |
2016-10-11 |
Activx Biosciences Inc |
composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
|
CA2699152C
(en)
|
2007-09-12 |
2015-11-24 |
Activx Biosciences, Inc. |
Spirocyclic aminoquinolones as gsk-3 inhibitors
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
US8439940B2
(en)
|
2010-12-22 |
2013-05-14 |
Cabochon Aesthetics, Inc. |
Dissection handpiece with aspiration means for reducing the appearance of cellulite
|
SG186008A1
(en)
|
2007-11-21 |
2012-12-28 |
Pharmaxis Ltd |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
JP2011506432A
(ja)
*
|
2007-12-10 |
2011-03-03 |
エピターゲット・アーエス |
非ラメラ形成脂質を含む音響感受性薬物送達粒子
|
US20090151241A1
(en)
*
|
2007-12-14 |
2009-06-18 |
Dressler Lawrence V |
Method for producing algae in photobioreactor
|
WO2009099767A2
(en)
|
2008-01-31 |
2009-08-13 |
C.R. Bard, Inc. |
Biopsy tissue marker
|
CN102014969B
(zh)
|
2008-02-29 |
2014-07-09 |
兰休斯医疗成像公司 |
用于包括灌注成像在内的应用的造影剂
|
WO2009111611A2
(en)
*
|
2008-03-05 |
2009-09-11 |
Proteotech Inc. |
Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
|
SI2947072T1
(sl)
|
2008-03-17 |
2017-03-31 |
Ambit Biosciences Corporation |
1-(3-(6,7-dimetoksikinazolin-4-iloksi)fenil)-3-(5-1,1,1-trifluoro-2- metilpropan-2-il)izoksazol-3-il)urea kot modulator raf kinaze pri zdravljenju rakavih bolezni
|
WO2009126764A1
(en)
|
2008-04-11 |
2009-10-15 |
Cytotech Labs, Llc |
Methods and use of inducing apoptosis in cancer cells
|
US8197857B2
(en)
*
|
2008-06-06 |
2012-06-12 |
Dressler Lawrence V |
Method for eliminating carbon dioxide from waste gases
|
GB0811856D0
(en)
|
2008-06-27 |
2008-07-30 |
Ucl Business Plc |
Magnetic microbubbles, methods of preparing them and their uses
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
US9327061B2
(en)
|
2008-09-23 |
2016-05-03 |
Senorx, Inc. |
Porous bioabsorbable implant
|
CA2748995C
(en)
*
|
2008-10-07 |
2018-01-16 |
Bracco Suisse Sa |
Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
|
BRPI0823399B8
(pt)
|
2008-12-30 |
2021-06-22 |
Bard Inc C R |
dispositivo de liberação de marcador para posicionamento de marcador de tecido
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US20100204570A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Paul Lubock |
Anchor markers
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
ES2456275T3
(es)
|
2009-02-27 |
2014-04-21 |
Ambit Biosciences Corporation |
Derivados de quinazolina moduladores de la quinasa JAK y su uso en métodos
|
WO2010101967A2
(en)
|
2009-03-04 |
2010-09-10 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole hcv polymerase inhibitors
|
CA2755120C
(en)
*
|
2009-03-11 |
2017-05-16 |
Kyorin Pharmaceutical Co., Ltd. |
7-cycloalkylaminoquinolones as gsk-3 inhibitors
|
CA2754909A1
(en)
|
2009-03-11 |
2010-09-16 |
Ambit Biosciences Corp. |
Combination of an indazolylaminopyrrolotriazine and taxane for cancer treatment
|
US9320877B2
(en)
*
|
2009-03-20 |
2016-04-26 |
Incube Labs, Llc |
Solid drug delivery apparatus and formulations and methods of use
|
CA2756067A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics, Inc. |
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
DK2419096T3
(da)
|
2009-04-15 |
2020-02-03 |
Lantheus Medical Imaging Inc |
Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre
|
CA2758985A1
(en)
|
2009-04-22 |
2010-10-28 |
Axikin Pharmaceuticals, Inc. |
2,5-disubstituted arylsulfonamide ccr3 antagonists
|
EP2502921B1
(de)
|
2009-04-22 |
2015-05-20 |
Axikin Pharmaceuticals, Inc. |
Arylsulfonamid-CCR-3-Antagonisten
|
RU2527165C2
(ru)
|
2009-04-22 |
2014-08-27 |
Аксикин Фармасьютикалз, Инк. |
2, 5-дизамещенные арилсульфонамидные антагонисты ссr3
|
SG10201402289VA
(en)
|
2009-05-11 |
2014-07-30 |
Berg Llc |
Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
AR080945A1
(es)
|
2009-07-07 |
2012-05-23 |
Pathway Therapeutics Inc |
Pirimidinil y 1,3,5-triazinil benzimidazoles y su uso en la terapia contra el cancer
|
PT2451435T
(pt)
|
2009-07-08 |
2018-01-15 |
Hope Medical Entpr Inc D B A Hope Pharmaceuticals |
Composições farmacêuticas que contêm tiossulfato de sódio
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
TW201117812A
(en)
|
2009-08-05 |
2011-06-01 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
US11096708B2
(en)
|
2009-08-07 |
2021-08-24 |
Ulthera, Inc. |
Devices and methods for performing subcutaneous surgery
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
US20130035326A1
(en)
|
2009-08-19 |
2013-02-07 |
Ambit Biosciences Corporation |
Biaryl compounds and methods of use thereof
|
WO2011029094A2
(en)
|
2009-09-04 |
2011-03-10 |
The University Of North Carolina At Chapel Hill |
Systems, methods, and computer readable media for high- frequency contrast imaging and image-guided therapeutics
|
WO2011034892A2
(en)
*
|
2009-09-15 |
2011-03-24 |
The Trustees Of Columbia University In The City Of New York |
Systems, methods, and devices for microbubbles
|
US20110118600A1
(en)
|
2009-11-16 |
2011-05-19 |
Michael Gertner |
External Autonomic Modulation
|
US20110092880A1
(en)
|
2009-10-12 |
2011-04-21 |
Michael Gertner |
Energetic modulation of nerves
|
US8986211B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8517962B2
(en)
|
2009-10-12 |
2013-08-27 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8295912B2
(en)
|
2009-10-12 |
2012-10-23 |
Kona Medical, Inc. |
Method and system to inhibit a function of a nerve traveling with an artery
|
US9174065B2
(en)
|
2009-10-12 |
2015-11-03 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8469904B2
(en)
|
2009-10-12 |
2013-06-25 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US9119951B2
(en)
|
2009-10-12 |
2015-09-01 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US20160059044A1
(en)
|
2009-10-12 |
2016-03-03 |
Kona Medical, Inc. |
Energy delivery to intraparenchymal regions of the kidney to treat hypertension
|
US8986231B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
TW201120037A
(en)
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
US20110301235A1
(en)
|
2009-12-02 |
2011-12-08 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
MY159958A
(en)
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
WO2011079313A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Map Pharmaceuticals, Inc. |
Novel ergoline analogs
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
PT3323810T
(pt)
|
2010-02-08 |
2022-04-14 |
Lantheus Medical Imaging Inc |
Sistema de reação automatizado, cassete e dispositivo para sintetizar agentes de imagem
|
CA2791964A1
(en)
|
2010-03-02 |
2011-09-09 |
Axikin Pharmaceuticals, Inc. |
Isotopically enriched arylsulfonamide ccr3 antagonists
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
SG183508A1
(en)
*
|
2010-03-12 |
2012-10-30 |
Berg Pharma Llc |
Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
|
JP5818873B2
(ja)
|
2010-03-17 |
2015-11-18 |
アクシキン ファーマシューティカルズ インコーポレーテッド |
アリールスルホンアミドccr3アンタゴニスト
|
US9078594B2
(en)
*
|
2010-04-09 |
2015-07-14 |
Hitachi, Ltd. |
Ultrasound diagnostic and treatment device
|
US9296722B2
(en)
|
2010-05-27 |
2016-03-29 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
EP2576513A1
(de)
|
2010-06-01 |
2013-04-10 |
Biotheryx Inc. |
Hydroxypyridonderivate, pharmazeutische zusammensetzungen daraus und ihre therapeutische verwendung zur behandlung von proliferativen erkrankungen
|
AU2011261501B2
(en)
|
2010-06-01 |
2016-01-21 |
Biotheryx, Inc. |
Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone
|
CN104860907A
(zh)
|
2010-06-07 |
2015-08-26 |
诺沃梅迪科斯有限公司 |
呋喃基化合物及其用途
|
MX347927B
(es)
|
2010-07-19 |
2017-05-19 |
Summa Health System |
Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
|
ITPI20100095A1
(it)
*
|
2010-07-28 |
2012-01-29 |
Giuseppe Sabino |
Un mezzo di contrasto ecografico antigene-specifico, un procedimento per la sua preparazione e suoi usi.
|
WO2012030885A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Hydrobromide salts of a pyrazolylaminoquinazoline
|
MX2013002384A
(es)
|
2010-09-01 |
2013-07-05 |
Ambit Biosciences Corp |
Compuestos quinazolina y metodos para utilizarlos.
|
WO2012030914A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Boisciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
EP2611793A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
2-cyclochinazolinderivate und verwendungsverfahren dafür
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
EP2611812A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
EP2663553B1
(de)
|
2010-09-01 |
2015-08-26 |
Ambit Biosciences Corporation |
Chinolin- und isochinolinverbindungen zur verwendung als jak-modulatoren
|
US8703943B2
(en)
|
2010-09-01 |
2014-04-22 |
Ambit Biosciences Corporation |
Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
EP2611809A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Azolopyridin- und azolopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
EP2611502A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Adenosin-a3-rezeptormodulierende verbindungen und ihre verwendung
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
WO2012048335A2
(en)
*
|
2010-10-08 |
2012-04-12 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
WO2012051090A1
(en)
|
2010-10-11 |
2012-04-19 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
AU2011338530B2
(en)
|
2010-12-06 |
2017-06-15 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
WO2012103165A2
(en)
|
2011-01-26 |
2012-08-02 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
CN103338753A
(zh)
|
2011-01-31 |
2013-10-02 |
细胞基因公司 |
胞苷类似物的药物组合物及其使用方法
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
SG193982A1
(en)
|
2011-03-28 |
2013-11-29 |
Mei Pharma Inc |
(alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
|
WO2012135175A1
(en)
|
2011-03-28 |
2012-10-04 |
Pathway Therapeutics Inc. |
(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
US20140088103A1
(en)
|
2011-03-28 |
2014-03-27 |
Mei Pharma, Inc. |
(fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
EP2694463B8
(de)
|
2011-04-04 |
2019-10-09 |
Berg LLC |
Behandlung von tumoren im zentralnervensystem mit coenzym q10
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
US20140239525A1
(en)
|
2011-06-17 |
2014-08-28 |
Board Of Regents, University Of Texas System |
Inhalable pharmaceutical compositions
|
EP2723735A4
(de)
|
2011-06-23 |
2015-02-18 |
Map Pharmaceuticals Inc |
Neue fluorergolin-analoga
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
US8822549B2
(en)
*
|
2011-10-13 |
2014-09-02 |
Jennifer L. Johnson |
Buffered oxygen therapeutic
|
HUE027745T4
(en)
|
2011-10-14 |
2017-09-28 |
Ambit Biosciences Corp |
Heterocyclic compounds and their use as a type III receptor tyrosine kinase modulator
|
US9057712B1
(en)
|
2011-10-27 |
2015-06-16 |
Copilot Ventures Fund Iii Llc |
Methods of delivery of encapsulated perfluorocarbon taggants
|
US8592445B2
(en)
|
2011-12-19 |
2013-11-26 |
Map Pharmaceuticals, Inc. |
Iso-ergoline derivatives
|
CA2859175A1
(en)
|
2011-12-21 |
2013-06-27 |
Map Pharmaceuticals, Inc. |
Novel neuromodulatory compounds
|
US9611253B2
(en)
|
2012-02-29 |
2017-04-04 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
AU2013205306B2
(en)
|
2012-03-16 |
2015-09-17 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
DK2844637T5
(en)
|
2012-05-02 |
2018-08-13 |
Boehringer Ingelheim Int |
SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS BY SSAO AND USES THEREOF
|
EP3406598B1
(de)
|
2012-06-14 |
2020-01-29 |
Mayo Foundation for Medical Education and Research |
Pyrazolderivate als hemmer von stat3
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
CN104519989B
(zh)
*
|
2012-06-26 |
2016-10-26 |
通用电气医疗集团股份有限公司 |
制备包含气体微泡的组合物
|
RU2681730C2
(ru)
|
2012-07-25 |
2019-03-12 |
Селлдекс Терапьютикс Инк. |
Антитела против kit и их применения
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CN103565745A
(zh)
|
2012-08-10 |
2014-02-12 |
德克萨斯州大学系统董事会 |
用于治疗中风的神经保护性脂质体组合物和方法
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
TW201414721A
(zh)
|
2012-09-07 |
2014-04-16 |
Axikin Pharmaceuticals Inc |
同位素濃化之芳磺醯胺ccr3拮抗劑
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
US9982290B2
(en)
|
2012-10-04 |
2018-05-29 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
EP2916830A2
(de)
|
2012-11-08 |
2015-09-16 |
Summa Health System |
Kombinationen aus vitamin c, vitamin k und einem polyphenol zur wundheilung
|
MX370519B
(es)
|
2012-11-30 |
2019-12-17 |
Novomedix Llc |
Sulfonamidas con sustitucion biarilo y su uso.
|
US8895743B2
(en)
|
2012-12-21 |
2014-11-25 |
Map Pharmaceuticals, Inc. |
Methysergide derivatives
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
CA2897665A1
(en)
|
2013-01-11 |
2014-07-17 |
Mayo Foundation For Medical Education And Research |
Vitamins c and k for treating polycystic diseases
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
AU2014233018A1
(en)
|
2013-03-15 |
2015-10-01 |
The Board Of Regents Of The University Of Texas System |
Liquids rich in noble gas and methods of their preparation and use
|
AU2014251045B2
(en)
|
2013-04-08 |
2019-06-13 |
Berg Llc |
Treatment of cancer using coenzyme Q10 combination therapies
|
ES2891755T3
(es)
|
2013-06-06 |
2022-01-31 |
Pf Medicament |
Anticuerpos anti-C10orf54 y utilizaciones de los mismos
|
KR20160055170A
(ko)
|
2013-08-30 |
2016-05-17 |
암비트 바이오사이언시즈 코포레이션 |
바이아릴 아세트아미드 화합물 및 이의 사용 방법
|
MX2016002873A
(es)
|
2013-09-04 |
2016-06-22 |
Berg Llc |
Metodos de tratamiento de cancer por infusion continua de coenzima q10.
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
USD715942S1
(en)
|
2013-09-24 |
2014-10-21 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716450S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716451S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715442S1
(en)
|
2013-09-24 |
2014-10-14 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
EP3450571B1
(de)
|
2014-02-24 |
2023-04-05 |
Celgene Corporation |
Verfahren zur verwendung eines aktivators von cereblon für neuronale zellexpansion und behandlung von erkrankungen des zentralnervensystems
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
WO2015134560A1
(en)
|
2014-03-05 |
2015-09-11 |
Idenix Pharmaceuticals, Inc. |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
JP6568926B2
(ja)
|
2014-03-20 |
2019-08-28 |
カペラ セラピューティクス,インコーポレーテッド |
癌の治療のためのerbbチロシンキナーゼ阻害剤としてのベンゾイミダゾール誘導体
|
TWI683813B
(zh)
|
2014-03-20 |
2020-02-01 |
美商卡佩拉醫療公司 |
苯并咪唑衍生物及其醫藥組合物及使用方法
|
WO2015143357A2
(en)
*
|
2014-03-21 |
2015-09-24 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating a lung
|
SG11201609256SA
(en)
|
2014-05-12 |
2016-12-29 |
Conatus Pharmaceuticals Inc |
Treatment of the complications of chronic liver disease with caspase inhibitors
|
SG10201912986PA
(en)
|
2014-05-28 |
2020-02-27 |
Agenus Inc |
Anti-gitr antibodies and methods of use thereof
|
US9527815B2
(en)
|
2014-06-18 |
2016-12-27 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
GB201411423D0
(en)
|
2014-06-26 |
2014-08-13 |
Ge Healthcare As |
Lipid sterilisation method
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
EP3179857B1
(de)
|
2014-08-14 |
2021-09-08 |
Mamoun M. Alhamadsheh |
Konjugation von pharmazeutischen wirkstoffen mit transthyretinliganden durch anpassbare linker zur erhöhung der serumshalbwertszeit
|
RU2723559C2
(ru)
|
2014-09-12 |
2020-06-16 |
Тобира Терапьютикс, Инк. |
Комбинированная терапия с применением препарата ценикривирок для лечения фиброза
|
EP3209658A1
(de)
|
2014-10-24 |
2017-08-30 |
Biogen MA Inc. |
Diterpenoidderivate und verfahren zur verwendung
|
US10925579B2
(en)
|
2014-11-05 |
2021-02-23 |
Otsuka Medical Devices Co., Ltd. |
Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
|
US10500227B2
(en)
*
|
2014-12-03 |
2019-12-10 |
University Of Cincinnati |
Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
|
ES2934940T3
(es)
|
2014-12-11 |
2023-02-28 |
Pf Medicament |
Anticuerpos anti-C10orf54 y utilizaciones de los mismos
|
CA2972048C
(en)
|
2014-12-22 |
2023-03-07 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
EA032473B1
(ru)
|
2014-12-23 |
2019-05-31 |
Аксикин Фармасьютикалз, Инк. |
3,5-диаминопиразоловые ингибиторы киназы
|
KR102618877B1
(ko)
|
2014-12-31 |
2023-12-28 |
랜티우스 메디컬 이메징, 인크. |
지질-캡슐화된 기체 마이크로스피어 조성물 및 관련 방법
|
CA2974117A1
(en)
|
2015-01-20 |
2016-07-28 |
Xoc Pharmaceuticals, Inc. |
Ergoline compounds and uses thereof
|
CA2974113A1
(en)
|
2015-01-20 |
2016-07-28 |
Xoc Pharmaceuticals, Inc. |
Isoergoline compounds and uses thereof
|
EP3250572B1
(de)
|
2015-01-28 |
2020-08-26 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
Substituierte imidazo[1,2-a]pyridin-2-ylamin-verbindungen und pharmazeutische zusammensetzungen sowie verfahren zur verwendung davon
|
HUE061070T2
(hu)
|
2015-03-03 |
2023-05-28 |
Kymab Ltd |
Ellenanyagok, alkalmazások és eljárások
|
MX2017015046A
(es)
|
2015-05-29 |
2018-05-17 |
Agenus Inc |
Anticuerpos anti-antigeno 4 del linfocito t citotoxico (ctla-4) y metodos para uso de los mismos.
|
CN107708581B
(zh)
|
2015-06-10 |
2021-11-19 |
Ekos公司 |
超声波导管
|
MX2017017015A
(es)
|
2015-06-23 |
2018-02-26 |
Neurocrine Biosciences Inc |
Inhibidores de transportador de monoamina vesicular tipo 2 (vmat2) para tratar enfermedades o trastornos neurologicos.
|
CN104984338A
(zh)
*
|
2015-06-23 |
2015-10-21 |
重庆医科大学 |
笑气作为细胞内超声空化效应增强剂的应用
|
CN114605548A
(zh)
|
2015-09-01 |
2022-06-10 |
艾吉纳斯公司 |
抗-pd-1抗体及其使用方法
|
LT3368534T
(lt)
|
2015-10-30 |
2021-04-12 |
Neurocrine Biosciences, Inc. |
Valbenazino ditozilatas ir jo polimorfai
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
SI3394057T1
(sl)
|
2015-12-23 |
2022-06-30 |
Neurocrine Biosciences, Inc. |
Sintetičen postopek za pripravo (S)-(2R,3R,11bR)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1H- pirido(2,1,-a)izokinolin-2-il 2-amino-3-metilbutanoat di(4-metilbenzensulfonata)
|
KR20180101418A
(ko)
|
2015-12-31 |
2018-09-12 |
코나터스 파마슈티칼스, 인크. |
간 질환의 치료에서의 카스파제 억제제의 사용 방법
|
JP7071922B2
(ja)
|
2016-01-08 |
2022-05-19 |
セルジーン コーポレイション |
2-(4-クロロフェニル)-n-((2-(2,6-ジオキソピペリジン-3-イル)-1-オキソイソインドリン-5-イル)メチル)-2,2-ジフルオロアセトアミドの固体形態、ならびにそれらの薬学的組成物及び使用
|
CN113662941A
(zh)
|
2016-01-08 |
2021-11-19 |
细胞基因公司 |
抗增殖化合物以及其药物组合物和用途
|
US10960013B2
(en)
|
2016-03-04 |
2021-03-30 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
US10064855B2
(en)
|
2016-03-08 |
2018-09-04 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
US10407437B2
(en)
|
2016-03-08 |
2019-09-10 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
WO2017180589A1
(en)
|
2016-04-11 |
2017-10-19 |
Auspex Pharmaceuticals, Inc. |
Deuterated ketamine derivatives
|
WO2017180794A1
(en)
|
2016-04-13 |
2017-10-19 |
Skyline Antiinfectives, Inc. |
Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
|
IL262647B2
(en)
*
|
2016-05-04 |
2023-03-01 |
Lantheus Medical Imaging Inc |
Methods and devices for preparing sharpness factors for ultrasound
|
EP3454904B1
(de)
|
2016-05-13 |
2022-12-14 |
Institut Pasteur |
Hemmung von beta-2-nicotinischen acetylcholinrezeptoren zur behandlung von morbus alzheimer
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
CA3024508A1
(en)
|
2016-05-27 |
2017-11-30 |
Agenus Inc. |
Anti-tim-3 antibodies and methods of use thereof
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
CN109689685A
(zh)
|
2016-07-08 |
2019-04-26 |
斯塔滕生物技术有限公司 |
抗apoc3抗体及其使用方法
|
WO2018035281A1
(en)
|
2016-08-17 |
2018-02-22 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
EP3515414B1
(de)
|
2016-09-19 |
2022-11-30 |
MEI Pharma, Inc. |
Kombinationstherapie
|
AU2017343621B2
(en)
|
2016-10-11 |
2021-12-02 |
Agenus Inc. |
Anti-LAG-3 antibodies and methods of use thereof
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
CA3042989A1
(en)
|
2016-11-07 |
2018-05-11 |
Junho Chung |
Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof
|
US10988442B2
(en)
|
2016-11-09 |
2021-04-27 |
Novomedix, Llc |
Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
US10106521B2
(en)
|
2016-11-09 |
2018-10-23 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
WO2018102252A1
(en)
|
2016-11-30 |
2018-06-07 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
EP3548007A4
(de)
|
2016-12-01 |
2020-08-12 |
Ignyta, Inc. |
Verfahren zur behandlung von krebs
|
EP3548027A1
(de)
|
2016-12-02 |
2019-10-09 |
Neurocrine Biosciences, Inc. |
Verwendung von valbenazin zur behandlung von schizophrenie oder schizoaffektiver störung
|
JP7106538B2
(ja)
|
2016-12-07 |
2022-07-26 |
アジェナス インコーポレイテッド |
抗体およびその使用方法
|
EP3551660B1
(de)
|
2016-12-07 |
2023-09-13 |
Agenus Inc. |
Anti-ctla-4-antikörper und verfahren zur verwendung davon
|
EA201991784A1
(ru)
|
2017-01-27 |
2021-09-23 |
Нейрокрин Байосайенсиз, Инк. |
Способы введения некоторых vmat2-ингибиторов
|
KR20190122698A
(ko)
|
2017-02-17 |
2019-10-30 |
캠리스 인터내셔널, 인코포레이티드 |
범용 해독제
|
AU2018222739B2
(en)
|
2017-02-17 |
2024-03-14 |
Eidos Therapeutics, Inc. |
Processes for preparing AG-10, its intermediates, and salts thereof
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
EP3601351A1
(de)
|
2017-03-27 |
2020-02-05 |
Celgene Corporation |
Verfahren und zusammensetzungen zur reduzierung der immunogenität
|
AU2018253176B2
(en)
|
2017-04-13 |
2023-02-02 |
Agenus Inc. |
Anti-CD137 antibodies and methods of use thereof
|
JP2020517242A
(ja)
|
2017-04-21 |
2020-06-18 |
スターテン・バイオテクノロジー・ベー・フェー |
抗ApoC3抗体およびその使用方法
|
WO2018200605A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
HUE062927T2
(hu)
|
2017-05-01 |
2023-12-28 |
Agenus Inc |
Anti-TIGIT ellenanyagok és alkalmazási eljárásaik
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
EP3630758A1
(de)
|
2017-06-01 |
2020-04-08 |
Xoc Pharmaceuticals, Inc |
Ergolinderivate zur verwendung in der medizin
|
JP7012384B2
(ja)
|
2017-06-27 |
2022-02-14 |
ニューラクル サイエンス カンパニー リミテッド |
癌治療のための抗fam19a5抗体の用途
|
WO2019003162A1
(en)
|
2017-06-27 |
2019-01-03 |
Neuracle Science Co., Ltd. |
USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, MEMBER A5, FOR THE TREATMENT OF GLAUCOMA
|
KR102340352B1
(ko)
|
2017-06-27 |
2021-12-21 |
주식회사 뉴라클사이언스 |
섬유증의 치료를 위한 항-fam19a5 항체의 용도
|
JP7076059B2
(ja)
|
2017-06-27 |
2022-05-27 |
ニューラクル サイエンス カンパニー リミテッド |
抗fam19a5抗体及びその用途
|
EP4265257A1
(de)
|
2017-09-01 |
2023-10-25 |
East Carolina University |
Kombination eines prostaglandin-ethanolamids der j-serie und eines checkpoint-inhibitors zur verwendung bei der behandlung von krebs
|
US20200276184A1
(en)
|
2017-09-21 |
2020-09-03 |
Neurocrine Biosciences, Inc. |
High Dosage Valbenazine Formulation and Compositions, Methods, and Kits Related Thereto
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
JP2021502959A
(ja)
|
2017-10-10 |
2021-02-04 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
特定のvmat2インヒビターを投与するための方法
|
AU2018361957B2
(en)
|
2017-10-31 |
2023-05-25 |
Staten Biotechnology B.V. |
Anti-ApoC3 antibodies and methods of use thereof
|
TW201929847A
(zh)
|
2018-01-10 |
2019-08-01 |
美商克拉治療有限責任公司 |
包含二羧酸之醫藥組合物及其治療應用
|
US11701334B2
(en)
|
2018-01-10 |
2023-07-18 |
Cura Therapeutics, Llc |
Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
|
KR102245539B1
(ko)
*
|
2018-02-12 |
2021-04-29 |
주식회사 지앤피바이오사이언스 |
코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물
|
TWI817999B
(zh)
|
2018-03-23 |
2023-10-11 |
美商文涵治療有限公司 |
使用ag10治療ttr澱粉樣沉積症之方法
|
WO2019191557A1
(en)
*
|
2018-03-29 |
2019-10-03 |
Case Wester Reserve University |
Stabilized nanobubbles and microbubbles for diagnostic and therapeutic applications
|
EP3823986A4
(de)
|
2018-04-24 |
2022-03-23 |
Neuracle Science Co., Ltd |
Verwendung von antikörpern gegen familie mit sequenzähnlichkeit 19, element a5 zur behandlung von neuropathischem schmerz
|
CN112638387A
(zh)
|
2018-06-14 |
2021-04-09 |
纽罗克里生物科学有限公司 |
Vmat2抑制剂化合物、组合物和与其相关的方法
|
EP3814327A1
(de)
|
2018-06-29 |
2021-05-05 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen
|
JP2021531007A
(ja)
|
2018-07-20 |
2021-11-18 |
ピエール、ファーブル、メディカマン |
Vistaに対する受容体
|
TW202021585A
(zh)
|
2018-08-15 |
2020-06-16 |
美商紐羅克里生物科學有限公司 |
用於特定vmat2抑制劑之投與之方法
|
MX2021001761A
(es)
|
2018-08-17 |
2021-04-19 |
Eidos Therapeutics Inc |
Formulaciones de ag10.
|
AU2019352017A1
(en)
|
2018-10-03 |
2021-05-06 |
Staten Biotechnology B.V. |
Antibodies specific for human and cynomolgus ApoC3 and methods of use thereof
|
KR20210093950A
(ko)
|
2018-11-16 |
2021-07-28 |
네오이뮨텍, 인코퍼레이티드 |
Il-7 단백질 및 면역 관문 저해제의 조합으로 종양을 치료하는 방법
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
US20230078755A1
(en)
|
2018-12-19 |
2023-03-16 |
Shy Therapeutics, Llc |
Compounds that Interact with the RAS Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
|
CN109602450B
(zh)
*
|
2019-01-29 |
2021-04-30 |
北京大学第三医院(北京大学第三临床医学院) |
一种超声腔内探头隔离及导声一体化装置
|
CN113874080A
(zh)
|
2019-02-06 |
2021-12-31 |
戴斯阿尔法公司 |
Il-17a调节剂及其用途
|
MA55080A
(fr)
|
2019-02-26 |
2022-01-05 |
Inspirna Inc |
Anticorps anti-mertk à affinité élevée et utilisations associées
|
TW202100506A
(zh)
|
2019-03-07 |
2021-01-01 |
美商柯納特斯製藥公司 |
半胱天冬酶(caspase)抑制劑及其使用方法
|
US20220249707A1
(en)
|
2019-05-20 |
2022-08-11 |
Nirvana Sciences Inc. |
Narrow emission dyes, compositions comprising same, and methods for making and using same
|
CA3146159A1
(en)
|
2019-07-11 |
2021-01-14 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
EP3997068A1
(de)
|
2019-07-11 |
2022-05-18 |
Cura Therapeutics, LLC |
Sulfonverbindungen und pharmazeutische zusammensetzungen daraus sowie ihre therapeutischen anwendungen zur behandlung von neurodegenerativen erkrankungen
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
JP2022545741A
(ja)
|
2019-08-30 |
2022-10-28 |
アジェナス インコーポレイテッド |
抗cd96抗体およびその使用方法
|
MX2022003166A
(es)
|
2019-09-16 |
2022-06-29 |
Dice Alpha Inc |
Moduladores de il-17a y usos de los mismos.
|
IL294663A
(en)
|
2020-01-13 |
2022-09-01 |
Neoimmunetech Inc |
A method for tumor treatment with a combination of il-7 protein and a bispecific antibody
|
EP4093751A1
(de)
|
2020-01-22 |
2022-11-30 |
Outpace Bio, Inc. |
Chimäre polypeptide
|
US20230210952A1
(en)
|
2020-02-05 |
2023-07-06 |
Washington University |
Method of treating a solid tumor with a combination of an il-7 protein and car-bearing immune cells
|
WO2021242970A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
US20230227466A1
(en)
|
2020-06-18 |
2023-07-20 |
Shy Therapeutics, Llc |
Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
CN111729093B
(zh)
*
|
2020-06-29 |
2022-05-24 |
南京超维景生物科技有限公司 |
一种造影剂成膜剂组合物、造影剂成膜脂液、造影剂及其制备方法
|
CN111617267A
(zh)
*
|
2020-07-07 |
2020-09-04 |
南京大学 |
一种包载全氟化碳的纳米级超声造影剂
|
US20240025863A1
(en)
|
2020-09-16 |
2024-01-25 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
TW202231269A
(zh)
|
2020-10-23 |
2022-08-16 |
美商拜歐斯瑞克斯公司 |
Kras蛋白降解劑、其醫藥組合物及其治療應用
|
WO2022094475A1
(en)
|
2020-11-02 |
2022-05-05 |
Neoimmunetech, Inc. |
Use of interleukin-7 for the treatment of coronavirus
|
AU2021376396A1
(en)
|
2020-11-05 |
2023-06-08 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
|
CN117203196A
(zh)
|
2020-12-14 |
2023-12-08 |
拜欧斯瑞克斯公司 |
Pde4降解剂、药物组合物和治疗应用
|
EP4284377A1
(de)
|
2021-01-27 |
2023-12-06 |
Shy Therapeutics LLC |
Verfahren zur behandlung von fibrotischen erkrankungen
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
CN117642396A
(zh)
|
2021-03-10 |
2024-03-01 |
戴斯分子Sv有限公司 |
αVβ6和αVβ1整联蛋白抑制剂及其用途
|
WO2022226166A1
(en)
|
2021-04-22 |
2022-10-27 |
Protego Biopharma, Inc. |
Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis
|
WO2022251533A1
(en)
|
2021-05-27 |
2022-12-01 |
Protego Biopharma, Inc. |
Heteroaryl diamide ire1/xbp1s activators
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022256437A1
(en)
|
2021-06-02 |
2022-12-08 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022263357A1
(en)
|
2021-06-14 |
2022-12-22 |
Argenx Iip Bv |
Anti-il-9 antibodies and methods of use thereof
|
CA3222240A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
US20230348909A1
(en)
|
2022-03-30 |
2023-11-02 |
Biomarin Pharmaceutical Inc. |
Dystrophin exon skipping oligonucleotides
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
WO2023201282A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Novel gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|